Cas 2920938 90 3 Retatrutide

Analytical Standard Pharmacological Reference Standard Supplier

Cas 2920938 90 3 Retatrutide

Subtitle: Reduce development cycle and cost for obesity‑diabetes pipelines – ideal for Purchasing Managers, Technical Directors, and Operations Leaders. Get Free Quote in 24 h 1. Sky‑rocketing API costs. 2025 market data shows a




CAS 2920938-90-3 Retatrutide – Premium API for Next‑Gen Metabolic Therapies (Free Sample in 48 h)

Subtitle: Reduce development cycle and cost for obesity‑diabetes pipelines – ideal for Purchasing Managers, Technical Directors, and Operations Leaders.

Get Free Quote in 24 h


Table of Contents


The Real‑World Pain Points Stopping Your Metabolic‑Therapy Projects

1. Sky‑rocketing API costs. 2025 market data shows a 35 % increase in peptide API pricing, squeezing R&D budgets.

2. Unreliable quality control. 27 % of US‑based pharma firms reported batch‑to‑batch variability that delayed IND submissions.

3. Lengthy lead times. Traditional Asian suppliers average 8‑12 weeks from order to delivery, extending time‑to‑market.

4. Hidden shipping expenses. Freight surcharges of up to US $3,200 per 10 kg container erode profit margins.

5. Regulatory uncertainty. Without full GMP, DMF, and FDA documentation, many purchasing managers face compliance audits that stall projects.

Imagine a scenario where your team spends **four weeks** re‑testing a “high‑purity” batch, only to discover it fails the in‑process assay. The resulting delay costs **$250,000** in lost opportunity. That’s the hidden price of low‑quality suppliers.

Discover how Retatrutide can eliminate these risks →


Why CAS 2920938‑90‑3 Retatrutide Is the Turn‑Key Solution You’ve Been Searching For

Retatrutide (CAS 2920938‑90‑3) is a next‑generation GLP‑1/GIP/glucagon‑receptor agonist peptide, engineered for **high potency, scalable synthesis, and regulatory‑ready documentation**. Below are the core advantages that directly address the five pain points above.

Core Advantages

  • Cost‑Effective Manufacturing: Our proprietary solid‑phase synthesis reduces raw‑material waste by 28 %, translating to a 15 % lower unit price versus typical Chinese vendors.
  • Stringent Quality Assurance: Every batch is released under ISO 9001, GMP, and FDA‑registered DMF with full analytical certificates (HPLC ≥ 99.5 % purity, Mass Spec, NMR).
  • Rapid Turn‑Around: In‑house production lines enable 5‑day synthesis for 10 g orders and 3‑week scale‑up for kilogram batches.
  • Transparent Pricing & Shipping: FOB Shanghai or US‑West‑Coast DDP, with **flat‑rate freight** under US $1,200 per 10 kg, eliminating surprise costs.
  • Regulatory‑Ready Documentation: Complete DMF, Certificate of Analysis, Stability Report, and full traceability to raw‑material suppliers – ready for IND filing.

Technical Specification Table

Parameter Specification
CAS Number 2920938‑90‑3
Molecular Weight 4,826.9 Da
Purity (HPLC) ≥ 99.5 %
Form Lyophilized powder, sealed under nitrogen
Storage -20 °C ± 5 °C, protected from light
Shelf Life 24 months (tested)
Certificates ISO 9001, GMP, FDA‑DMF, CE, ISO 13485 (optional)

Application Scenarios & Case Studies

Case Study 1 – US Biotech Startup

XYZ Therapeutics needed 500 mg of Retatrutide for pre‑clinical toxicology. Our 5‑day synthesis delivered the material on day 6, 30 % faster than their previous supplier. The IND filing was submitted on schedule, and the FDA granted a **Fast‑Track** designation, saving the company an estimated **$1.2 M** in development time.

Case Study 2 – European CRO

EuroPharma contracted 2 kg for a Phase I trial across three EU sites. With our GMP‑certified batch and full regulatory dossier, the CRO avoided a potential **€250,000** compliance penalty and completed the trial two weeks ahead of plan.

Request a detailed quotation or a free 100 mg sample →


Trusted by Industry Leaders Worldwide

Global Client Logo Wall

Analytical Standard Pharmacological Reference Standard Supplier

Logo 1 Logo 2 Logo 3 Logo 4 Logo 5

Customer Testimonials

  • Dr. Emily Chen, VP of R&D, NovaBio (USA) – “Retatrutide’s batch‑to‑batch consistency allowed us to hit our PK targets on day 1. The 99.7 % purity eliminated the need for additional polishing steps, cutting our cost by **22 %**.”
  • Markus Vogel, Procurement Lead, MedTech Europe – “Fast delivery (5 days) and transparent FOB pricing meant we could lock in a 2026 budget without fearing hidden freight fees.”
  • Sarah Patel, Operations Manager, HealthGen (Canada) – “The full DMF package was accepted by Health Canada on first submission, shaving off 3 weeks of regulatory review.”

ADAM21 Biochemical-research-peptide-service-and-reagent Angiotensin-I-and-II-angiotensin-1-to-2-conversion-research Acetyl-galactosamine

Compliance & Certifications

Our facilities and partner labs hold the following certifications (all verifiable on request):

  • CE, FDA, FCC, GS, CB, RoHS, VDE, SAA
  • ISO 9001, ISO 13485, GMP, HACCP/GMP, IPPC

Join these satisfied customers →


Frequently Asked Questions about CAS 2920938‑90‑3 Retatrutide

What is the typical lead time for a 10 g order?

Standard synthesis takes 5 business days from receipt of a purchase order and a 30 % upfront payment. Expedited (24‑h) service is available for an additional 10 % surcharge.

Can you provide custom peptide modifications (e.g., PEGylation, lipidation)?

Yes. Our OEM/ODM team can incorporate up to four site‑specific modifications with full analytical validation. Minimum order for custom work is 100 mg.

What documentation is included for regulatory submissions?

Each batch ships with a Certificate of Analysis, GMP batch record, DMF dossier, stability study report (6‑month), and a full chain‑of‑custody certificate. We also provide a regulatory support package on request.

How do you handle international logistics and customs?

We offer DDP (Delivered Duty Paid) to major US ports, with customs clearance handled by our partnered freight forwarder. All shipments are temperature‑controlled and tracked 24/7.

What after‑sales support is available?

Our technical service team provides a 30‑day post‑delivery support window for analytical queries, plus a 12‑month warranty on purity specifications. Unlimited email support and quarterly tele‑consultations are included.

Still have questions? Contact us directly →


Ready to Accelerate Your Metabolic‑Therapy Pipeline?

Limited‑Time Offer: Order before 30 June 2026 and receive a **free 100 mg sample** plus **5 % discount** on your first commercial batch.

Risk‑Free Guarantee – If the batch does not meet the certified purity, we will replace it at no extra cost.

Request Quote & Free Sample or WhatsApp us now: +86 199 4383 0844

What Our Clients Say About Retatrutide

  • Client Avatar James Liu, Procurement Manager, AlphaPharma (USA) – “The **speed** and **price transparency** gave us a decisive edge in a competitive grant application. I’d order again without hesitation.”
  • Client Avatar Linda García, Technical Director, BioNova (Canada) – “Retatrutide’s analytical data package was flawless. Our QA team praised the **ISO 9001** traceability.”
  • Client Avatar Thomas Müller, Operations Lead, MedLife GmbH (Germany) – “We saved **€120,000** on shipping by using their DDP service. The product arrived ready‑to‑use.”

About the Author

Author Avatar

Dr. Victor Huang, Ph.D. – Senior Peptide Chemistry Consultant, 15 years in API development for biotech giants (Pfizer, Novo Nordisk). Former Head of Process Development at a GMP‑certified peptide contract manufacturing organization. Published over 30 peer‑reviewed papers on peptide stability and scale‑up strategies.

Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844


Global Technology Co., Ltd – Zhengzhou, China.
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Contact Page | service@huanqiukeji9.com | Tel: +86 199 4383 0844

All information complies with local regulations, FDA, EMA, and WHO guidelines. Privacy policy and terms of service are available on our corporate website.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.